St Joseph Continuing Care Center | |
2301 Sterlington Road, Monroe, Louisiana 71203 | |
(318) 323-3426 | |
Name | St Joseph Continuing Care Center |
---|---|
Location | 2301 Sterlington Road, Monroe, Louisiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 130 |
Occupancy Rate | 65.15% |
Medicare ID (CCN) | 195359 |
Legal Business Name | Monroe Continuing Care Center L.c. |
Ownership Type | Non Profit - Corporation |
NPI Number | 1205461076 |
Organization Name | MONROE CONTINUING CARE CENTER L.C. |
Address | 2301 Sterlington Rd, Monroe, LA 71203 |
Phone Number | 318-323-3426 |
News Archive
Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms; however, the anatomic support deteriorates over time; and that adding an anti-incontinence procedure decreases, but does not eliminate the risk of stress urinary incontinence, and mesh erosion can be a problem, according to a study in the May 15 issue of JAMA.
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
The first National Open Access Framework in Italy for Biomedical Institutions has today been signed by the Italian consortium of Biomedical Research Libraries - Bibliosan - and the leading open access publisher, Frontiers.
Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.
› Verified 5 days ago
NPI Number | 1306802954 |
Organization Name | CHRISTUS HEALTH CENTRAL LOUISIANA |
Doing Business As | CHRISTUS ST. JOSEPH HOME |
Address | 2301 Sterlington Rd, Monroe, LA 71203 |
Phone Number | 318-323-3426 |
News Archive
Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms; however, the anatomic support deteriorates over time; and that adding an anti-incontinence procedure decreases, but does not eliminate the risk of stress urinary incontinence, and mesh erosion can be a problem, according to a study in the May 15 issue of JAMA.
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
The first National Open Access Framework in Italy for Biomedical Institutions has today been signed by the Italian consortium of Biomedical Research Libraries - Bibliosan - and the leading open access publisher, Frontiers.
Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms; however, the anatomic support deteriorates over time; and that adding an anti-incontinence procedure decreases, but does not eliminate the risk of stress urinary incontinence, and mesh erosion can be a problem, according to a study in the May 15 issue of JAMA.
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
The first National Open Access Framework in Italy for Biomedical Institutions has today been signed by the Italian consortium of Biomedical Research Libraries - Bibliosan - and the leading open access publisher, Frontiers.
Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.08 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.15 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 26.25 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.34 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.42 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.59 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.41 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.18 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.12 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.31 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.99 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.43 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 15.6 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99 | 95.98 |
Percentage of short-stay residents who made improvements in function | 76.15 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.51 | 82.93 |
News Archive
Results after seven years of follow-up suggest that women considering abdominal sacrocolpopexy (surgery for pelvic organ prolapse [POP]) should be counseled that this procedure effectively provides relief from POP symptoms; however, the anatomic support deteriorates over time; and that adding an anti-incontinence procedure decreases, but does not eliminate the risk of stress urinary incontinence, and mesh erosion can be a problem, according to a study in the May 15 issue of JAMA.
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
The first National Open Access Framework in Italy for Biomedical Institutions has today been signed by the Italian consortium of Biomedical Research Libraries - Bibliosan - and the leading open access publisher, Frontiers.
Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.
› Verified 5 days ago
St Joseph Continuing Care Center Location: 2301 Sterlington Road, Monroe, Louisiana 71203 Phone: (318) 323-3426 | |
Delta Grande Skilled Nursing And Rehabilitation Location: 3001 South Grande Street, Monroe, Louisiana 71202 Phone: (318) 322-3100 | |
Ouachita Healthcare And Rehabilitation Center Location: 7950 Millhaven Road, Monroe, Louisiana 71203 Phone: (318) 737-1117 | |